Ad
LJPC Quote Trading Chart La Jolla Pharmaceutical Company
home / stock / ljpc / ljpc quote
Quote | La Jolla Pharmaceutical Company (NASDAQ:LJPC)
| Last: | $6.22 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $6.21 |
| Close: | $6.22 |
| High: | $6.24 |
| Low: | $6.2 |
| Volume: | 267,682 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
LJPC Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $6.22 | $6.21 | $6.22 | $6.24 | $6.2 | 267,682 | 08-19-2022 |
| $6.22 | $6.18 | $6.22 | $6.22 | $6.16 | 341,015 | 08-18-2022 |
| $6.17 | $6.19 | $6.17 | $6.205 | $5.82 | 1,482,763 | 08-17-2022 |
| $6.2 | $6.21 | $6.2 | $6.22 | $6.19 | 1,771,251 | 08-16-2022 |
| $6.19 | $6.2 | $6.19 | $6.22 | $6.19 | 960,928 | 08-15-2022 |
| $6.21 | $6.2 | $6.21 | $6.21 | $6.2 | 62,430 | 08-12-2022 |
| $6.2 | $6.21 | $6.2 | $6.21 | $6.2 | 56,890 | 08-11-2022 |
| $6.2 | $6.2 | $6.2 | $6.21 | $6.2 | 82,292 | 08-10-2022 |
| $6.2 | $6.2 | $6.2 | $6.21 | $6.2 | 92,682 | 08-09-2022 |
| $6.2 | $6.2 | $6.2 | $6.21 | $6.2 | 156,992 | 08-08-2022 |
| $6.2 | $6.2 | $6.2 | $6.21 | $6.2 | 73,611 | 08-05-2022 |
| $6.2 | $6.21 | $6.2 | $6.22 | $6.2 | 97,971 | 08-04-2022 |
| $6.22 | $6.21 | $6.22 | $6.22 | $6.21 | 111,342 | 08-03-2022 |
| $6.21 | $6.2 | $6.21 | $6.22 | $6.2 | 140,991 | 08-02-2022 |
| $6.2 | $6.19 | $6.2 | $6.21 | $6.19 | 245,424 | 08-01-2022 |
| $6.21 | $6.2 | $6.21 | $6.22 | $6.19 | 134,759 | 07-29-2022 |
| $6.2 | $6.19 | $6.2 | $6.21 | $6.19 | 121,376 | 07-28-2022 |
| $6.2 | $6.2 | $6.2 | $6.22 | $6.19 | 139,196 | 07-26-2022 |
| $6.19 | $6.2 | $6.19 | $6.2 | $6.18 | 207,777 | 07-19-2022 |
| $6.19 | $6.17 | $6.19 | $6.2 | $6.16 | 244,073 | 07-18-2022 |
Stock Information
Get LJPC Alerts
News, Short Squeeze, Breakout and More Instantly...
La Jolla Pharmaceutical Company Company Name:
LJPC Stock Symbol:
NASDAQ Market:
0.0% G/L:
$6.22 Last:
267,682 Volume:
$6.21 Open:
$6.22 Close:
La Jolla Pharmaceutical Company Website:
Ad
Important Investor News Alert (NASDAQ: CVKD)
-
LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascular (CV) events such as stroke Hospitalization costs for patients following a major bleeding event associated with oral anticoagulation use averages $39,000 per ev...